Through the Worm Hole (Part 2) – Welcome to Alphabet Soup, Government Pricing, and the Acronyms That Come Along
Chris Cobourn, Managing Director, Huron Life Sciences
This is Part 2 of a series of articles designed to help life sciences compliance professionals understand the complex, and sometimes contradictory, universes of publicly funded health programs, such as Medicaid and Medicare, and the impact on participating drug manufacturers. This article focuses on the operational requirements of the programs for drug manufacturers in the US. In Part 3 of the series, we will look at how to evaluate Compliance, and what manufacturers should do to ensure that they are in full compliance with the programs.